Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Acta Neuropathol ; 141(3): 399-413, 2021 03.
Article in English | MEDLINE | ID: mdl-33517535

ABSTRACT

Neuropathologic hallmarks of Huntington Disease (HD) include the progressive neurodegeneration of the striatum and the presence of Huntingtin (HTT) aggregates that result from abnormal polyQ expansion of the HTT gene. Whether the pathogenic trinucleotide repeat expansion of the HTT gene causes neurodevelopmental abnormalities has garnered attention in both murine and human studies; however, documentation of discrete malformations in autopsy brains of HD individuals has yet to be described. We retrospectively searched the New York Brain Bank (discovery cohort) and an independent cohort (validation cohort) to determine whether developmental malformations are more frequently detected in HD versus non-HD brains and to document their neuropathologic features. One-hundred and thirty HD and 1600 non-HD whole brains were included in the discovery cohort and 720 HD and 1989 non-HD half brains were assessed in the validation cohort. Cases with developmental malformations were found at 6.4-8.2 times greater frequency in HD than in non-HD brains (discovery cohort: OR 8.68, 95% CI 3.48-21.63, P=4.8 × 10-5; validation cohort: OR 6.50, 95% CI 1.83-23.17, P=0.0050). Periventricular nodular heterotopias (PNH) were the most frequent malformations and contained HTT and p62 aggregates analogous to the cortex, whereas cortical malformations with immature neuronal populations did not harbor such inclusions. HD individuals with malformations had heterozygous HTT CAG expansions between 40 and 52 repeats, were more frequently women, and all were asymmetric and focal, aside from one midline hypothalamic hamartoma. Using two independent brain bank cohorts, this large neuropathologic series demonstrates an increased occurrence of developmental malformations in HD brains. Since pathogenic HTT gene expansion is associated with genomic instability, one possible explanation is that neuronal precursors are more susceptible to somatic mutation of genes involved in cortical migration. Our findings further support emerging evidence that pathogenic trinucleotide repeat expansions of the HTT gene may impact neurodevelopment.


Subject(s)
Brain/pathology , Huntington Disease/pathology , Nervous System Malformations/epidemiology , Neurogenesis/physiology , Neurons/pathology , Adult , Aged , Cell Movement/physiology , Female , Humans , Male , Middle Aged , Nervous System Malformations/pathology , Retrospective Studies
2.
Neurology ; 73(15): 1200-6, 2009 Oct 13.
Article in English | MEDLINE | ID: mdl-19822869

ABSTRACT

BACKGROUND: Bevacizumab has recently been approved by the US Food and Drug Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and outcome of further therapy after bevacizumab failure have not been studied systematically. METHODS: We identified patients at Memorial Sloan-Kettering Cancer Center with recurrent GBM who discontinued bevacizumab because of progressive disease. RESULTS: There were 37 patients (26 men with a median age of 54 years). The most common therapies administered concurrently with bevacizumab were irinotecan (43%) and hypofractionated reirradiation (38%). The median overall survival (OS) after progressive disease on bevacizumab was 4.5 months; 34 patients died. At the time bevacizumab was discontinued for tumor progression, 17 patients (46%) had an increase in the size of enhancement at the initial site of disease (local recurrence), 6 (16%) had a new enhancing lesion outside of the initial site of disease (multifocal), and 13 (35%) had progression of predominantly nonenhancing tumor. Factors associated with shorter OS after discontinuing bevacizumab were lower performance status and nonenhancing pattern of recurrence. Additional salvage chemotherapy after bevacizumab failure was given to 19 patients. The median progression-free survival (PFS) among these 19 patients was 2 months, the median OS was 5.2 months, and the 6-month PFS rate was 0%. CONCLUSIONS: Contrast enhanced MRI does not adequately assess disease status during bevacizumab therapy for recurrent glioblastoma (GBM). A nonenhancing tumor pattern of progression is common after treatment with bevacizumab for GBM and is correlated with worse survival. Treatments after bevacizumab failure provide only transient tumor control.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal/therapeutic use , Brain Neoplasms/drug therapy , Drug Resistance, Neoplasm/drug effects , Glioblastoma/drug therapy , Adult , Aged , Antibodies, Monoclonal, Humanized , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bevacizumab , Brain Neoplasms/mortality , Brain Neoplasms/therapy , Disease-Free Survival , Female , Glioblastoma/mortality , Glioblastoma/therapy , Humans , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local , Prognosis , Retrospective Studies , Salvage Therapy , Treatment Failure
3.
Neurology ; 57(4): 716-8, 2001 Aug 28.
Article in English | MEDLINE | ID: mdl-11524489

ABSTRACT

Most primary CNS lymphomas (PCNSL) are B-cell neoplasms; T-cell lymphomas are quite rare. The authors report two young patients with T-cell PCNSL who had a complete response to chemo- and radiotherapy but developed recurrent disease and died 11 and 13 months from diagnosis. The prognosis of T-cell PCNSL may be worse than that of comparable B-cell tumors.


Subject(s)
Central Nervous System Neoplasms/diagnosis , Lymphoma, T-Cell/diagnosis , Adult , Antimetabolites, Antineoplastic/therapeutic use , Central Nervous System Neoplasms/drug therapy , Central Nervous System Neoplasms/radiotherapy , Cytarabine/therapeutic use , Fatal Outcome , Humans , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/radiotherapy , Male , Methotrexate/therapeutic use , Neoplasm Recurrence, Local/pathology , Prognosis
4.
J Neurovirol ; 7(1): 61-5, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11519484

ABSTRACT

Persons co-infected with HTLV-1 and HIV are at increased risk for neurologic disease. These patients may develop HAM/TSP and/or HIV-associated dementia. In this study, we localized cells infected with retrovirus in the central nervous system (CNS) of a patient with both HAM/TSP and HIV-associated dementia. HTLV-1 was localized to astrocytes and HIV to macrophage/microglia. There was no co-infection of a single cell phenotype in this patient. These data suggest that mechanisms other than co-infection of the same CNS cell may play a role in the development of neurologic disease in patients dual infected with HTLV-1 and HIV.


Subject(s)
AIDS Dementia Complex/virology , Central Nervous System/virology , Paraparesis, Tropical Spastic/virology , Retroviridae/isolation & purification , AIDS Dementia Complex/complications , AIDS Dementia Complex/pathology , Adult , Astrocytes/pathology , Astrocytes/virology , Brain/pathology , Brain/virology , Central Nervous System/pathology , DNA, Viral/analysis , Fatal Outcome , Gene Products, tax/genetics , HIV/genetics , HIV/isolation & purification , Human T-lymphotropic virus 1/genetics , Human T-lymphotropic virus 1/isolation & purification , Humans , Immunohistochemistry , In Situ Hybridization , Macrophages/pathology , Macrophages/virology , Male , Microglia/pathology , Microglia/virology , Paraparesis, Tropical Spastic/complications , Paraparesis, Tropical Spastic/pathology , Polymerase Chain Reaction , RNA, Viral/analysis , Retroviridae/genetics , Sarcoma, Kaposi/complications , Sarcoma, Kaposi/diagnosis , Spinal Cord/pathology , Spinal Cord/virology
5.
Am J Surg Pathol ; 25(6): 699-709, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11395547

ABSTRACT

Sclerosing epithelioid fibrosarcoma (SEF) is an uncommon tumor of deep soft tissues, originally described in 1995 by Meis-Kindblom et al. In the current study, the authors identified 16 cases of SEF in the pathology files of their institutions and studied their pathologic features and disease course. The group consisted of six male and 10 female patients (age range, 14-55 years; mean age, 40 years), and the tumors were located in a limb or limb girdle (n = 7), base of the penis (n = 1), back or chest wall (n = 3), and head and neck (n = 5). Tumor size ranged from 3.7 to 22 cm (mean, 8.9 cm). Histologically, the SEFs were composed predominantly of small to moderate-size round to ovoid, relatively uniform cells, often with clear cytoplasm, embedded in a hyalinized fibrous stroma. The only consistent immunohistochemical finding was a strong, diffuse reactivity of tumor cells for vimentin. Ultrastructural analysis performed in eight cases confirmed their fibroblastic nature. Bone invasion and tumor necrosis, features not reported before, were found in six cases each. Treatment consisted of intralesional excision (n = 2), attempted wide local excision (n = 11), and amputation (n = 3), with either adjuvant radiation therapy (n = 9) or chemotherapy (n = 3). Follow-up of at least 1 year in 14 cases revealed persistent disease or local recurrence in seven patients (50%), and distant metastasis in 12 patients (86%). Eight patients (57%) died of disease 16 to 86 months after diagnosis. Five patients were alive with disease as of last follow-up. SEF shares some pathologic features with two other fibrosing fibrosarcomas, low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes, but in the authors' experience behaves clinically as a fully malignant sarcoma.


Subject(s)
Fibrosarcoma/pathology , Soft Tissue Neoplasms/pathology , Adolescent , Adult , Female , Humans , Male , Microscopy, Electron , Middle Aged
6.
J Neurooncol ; 51(1): 51-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11349881

ABSTRACT

Ewing sarcoma/'peripheral' primitive neuroectodermal tumor (ES/pPNET) is the designation given to a family of small cell neoplasms that typically arise in bone or soft tissue and are unified by their common expression of the MIC2 antigen and specific translocations involving a gene on chromosome 22q12 [the most common being t(11;22)(q24;q12)]. ES/pPNET of intracranial origin is extraordinary. We report the case of a 6-year-old boy with a large left frontal region mass that adhered to dura and was extracerebral at surgery. Histologic study revealed a high-grade, undifferentiated-appearing neoplasm of small cell type that was negative on immunostudy for glial fibrillary acidic protein, synaptophysin, desmin, leukocyte common antigen, smooth muscle actin and epithelial membrane antigen, but positive for vimentin and neuron-specific enolase and diffusely labeled by antibody O13 (which recognizes the MIC2 gene product). RNA-based polymerase chain reaction assay confirmed the diagnosis of ES/pPNET by demonstrating fusion transcripts indicative of t(11;22) translocation. Bone scan, computerized tomography of the chest and bone marrow examination revealed no systemic tumor. The limited observations published to date suggest that primary intracranial ES/pPNET is most likely to present in childhood as a circumscribed, contrast-enhancing and dural-based extracerebral mass. It must be distinguished from a variety of small cell neoplasms, particularly PNETs of central neuroepithelial origin.


Subject(s)
Brain Neoplasms/diagnosis , Frontal Lobe , Neuroectodermal Tumors, Primitive, Peripheral/diagnosis , Polymerase Chain Reaction , Sarcoma, Ewing/diagnosis , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Child , Humans , Male , Neuroectodermal Tumors, Primitive, Peripheral/metabolism , Neuroectodermal Tumors, Primitive, Peripheral/pathology , Sarcoma, Ewing/metabolism , Sarcoma, Ewing/pathology
8.
Am J Surg Pathol ; 25(4): 494-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11257624

ABSTRACT

The authors report a series of 10 low-grade neoplasms arising in the midline anteriorly in the region of the septum pellucidum with many of the histologic features of dysembryoplastic neuroepithelial tumor (DNT). The patients (five female, five male) ranged in age from 6 to 35 years (mean age, 21.5 years). The most common presenting symptoms were headache, nausea and vomiting, and visual disturbances. Radiographically, the tumors extended into the lateral ventricles from the septal region and obstructed the foramen of Monro. Varying degrees of hydrocephalus were present. The lesions were lobular, well-delineated, hypointense to brain on T1-weighted magnetic resonance imaging, and hyperintense on T2-weighted images. They were uniformly nonenhancing or showed only minimal peripheral enhancement. The tumors, in aggregate, had the histologic features of DNT. These included a mucin-rich background, oligodendrocyte-like cells, "floating neurons," and a "specific glioneuronal element." Seven patients underwent gross total resection and two underwent subtotal resection. No patients received adjuvant chemotherapy or radiotherapy. On follow-up (n = 6; median, 14 months), all tumors had either not recurred or were radiologically stable. On the basis of both neuroimaging and histopathology, DNT-like lesions should be considered in the differential diagnosis of midline intraventricular tumors in children and young adults. Distinction from more aggressive neoplasms is essential because these tumors appear to behave in a benign fashion.


Subject(s)
Brain Neoplasms/pathology , Glioma/diagnosis , Neuroectodermal Tumors, Primitive/pathology , Septum Pellucidum/pathology , Teratoma/pathology , Adolescent , Adult , Biomarkers, Tumor/analysis , Brain Neoplasms/chemistry , Brain Neoplasms/surgery , Child , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male , Neoplasm Proteins/analysis , Neuroectodermal Tumors, Primitive/chemistry , Neuroectodermal Tumors, Primitive/surgery , Septum Pellucidum/chemistry , Septum Pellucidum/surgery , Teratoma/chemistry , Teratoma/surgery , Treatment Outcome
9.
Neurosurgery ; 47(4): 956-9; discussion 959-60, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11014436

ABSTRACT

OBJECTIVE AND IMPORTANCE: Sclerosing epithelioid fibrosarcoma (SEF) is a rare mesenchymal neoplasm composed of rounded, vimentin-immunoreactive tumor cells disposed in nests and cords within a hyalinized collagenous matrix. Most examples arise in the deep skeletal muscles of adults. The cases recorded to date have been characterized by protracted clinical evolutions with a tendency for stubborn local recurrence, followed by late metastasis. Accordingly, SEF has been regarded as a low-grade sarcoma. A single instance of brain and vertebral metastasis has been described. We report three examples of SEF distinguished by primary involvement of the neuraxis at initial presentation. CLINICAL PRESENTATION: Two tumors had intracranial, calvarial and extracalvarial, soft-tissue components, whereas the third tumor manifested as a paraspinal mass with extension into the T12-L1 neural foramen and invasion of the T12 nerve root. INTERVENTION: All three affected patients experienced local recurrence and distant metastasis after resection of the primary site. These complications appeared early in the disease course in two cases. In no case was there a response to adjuvant chemotherapy or radiotherapy. CONCLUSION: Our experience indicates that SEFs arising along the neuraxis may demonstrate unexpectedly aggressive clinical behavior, compared with those arising in the more typical location of deep skeletal muscles.


Subject(s)
Brain Neoplasms/diagnosis , Fibrosarcoma/diagnosis , Spinal Cord Neoplasms/diagnosis , Adolescent , Brain Neoplasms/pathology , Brain Neoplasms/surgery , Female , Fibrosarcoma/pathology , Fibrosarcoma/radiotherapy , Fibrosarcoma/surgery , Humans , Magnetic Resonance Imaging , Middle Aged , Neoplasm Invasiveness , Sclerosis , Spinal Cord Neoplasms/pathology , Spinal Cord Neoplasms/radiotherapy , Spinal Cord Neoplasms/surgery , Tomography, X-Ray Computed
10.
Pediatr Neurosurg ; 32(4): 214-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10940774

ABSTRACT

Pediatric gliomas span a spectrum of neoplasms ranging from the well-circumscribed, slowly growing lesions that can be totally removed by surgery to highly infiltrating, nonexcisable, rapidly growing tumors that resist any form of postoperative therapy. As part of this symposium, we discuss selected members of this group in the diencephalon, where lesions of both extremes are common in children. The report illustrates and contrasts the clinical, radiographic and pathological features of the two classic regional astrocytomas, pilocytic and fibrillary, as well as two less common but distinctive lesions, pilomyxoid astrocytoma and bithalamic astrocytoma.


Subject(s)
Astrocytoma/pathology , Brain Neoplasms/pathology , Diencephalon/pathology , Child , Humans , Neoplasm Invasiveness , Thalamus/pathology
11.
Am J Surg Pathol ; 23(10): 1270-5, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10524529

ABSTRACT

Fibro-osseous lesions, also reported as calcifying pseudoneoplasms of the neural axis, are uncommon lesions of the CNS. We report four additional cases: two extraaxial and two intraaxial, in patients ages 33, 47, 49, and 59 years at presentation. Fibro-osseous lesions involving the CNS demonstrate variable proportions of fibrous stroma, bone, palisading spindle to epithelioid to multinucleated cells in association with a highly distinctive, perhaps pathognomonic, chondromyxoid-like matrix often distributed in a nodular pattern. This histopathologically distinctive lesion can be seen in many regions of the neuraxis, often with a dural association, and most commonly along the vertebral column. It appears to be a slow-growing lesion and, with wide excision, the prognosis is excellent. The etiology remains unclear, but the preponderance of data favors a reactive rather than neoplastic process. If this putative pseudotumor is not recognized histopathologically, a neoplastic or infectious differential might result in inappropriate investigations and potentially harmful therapies.


Subject(s)
Calcinosis/pathology , Central Nervous System Diseases/pathology , Granuloma/pathology , Adult , Biomarkers, Tumor/metabolism , Calcinosis/metabolism , Calcinosis/surgery , Cartilage/pathology , Central Nervous System Diseases/metabolism , Central Nervous System Diseases/surgery , Female , Granuloma/metabolism , Granuloma/surgery , Humans , Immunoenzyme Techniques , Male , Middle Aged , Treatment Outcome
12.
Am J Surg Pathol ; 23(5): 502-10, 1999 May.
Article in English | MEDLINE | ID: mdl-10328080

ABSTRACT

Four examples of a novel glioneuronal neoplasm are presented. All tumors affected adults (including two males and two females aged 25-40 years) as supratentorial, cerebral hemispheric masses with associated seizure activity and, in one case, symptoms of raised intracranial pressure and progressive hemiparesis. CT scans in two cases revealed hypodense masses without calcification. MRI scans at presentation demonstrated, in all cases, solid T1-hypointense and T2-hyperintense tumors with mass effect in one instance but no edema or contrast enhancement. Only one was relatively circumscribed on neuroradiologic study. All were infiltrative in their histologic growth pattern and predominantly glial in appearance, being composed mainly of fibrillary, gemistocytic, or protoplasmic astroglial elements of WHO grade II to III. Their distinguishing feature was their content of sharply delimited, neuropil-like islands of intense synaptophysin reactivity inhabited and rimmed in rosetted fashion by cells demonstrating strong nuclear immunolabeling for the neuronal antigens NeuN and Hu. These cells included small, oligodendrocyte-like ("neurocytic") elements as well as larger, more pleomorphic forms. Two cases contained, in addition, well-differentiated neurons of medium to ganglion-cell size. Proliferative activity was observed principally within the glial compartment; two cases contained mitotic figures and exhibited relatively elevated MIB-1 indices (6.8% and 8.2%). One of the latter progressed and proved fatal at 30 months following subtotal resection and radiotherapy. The three other patients are alive at intervals of 14 to 83 months, two tumor-free and one with extensive disease associated with the appearance of enhancement on MRI. This glioneuronal tumor variant may pursue an unfavorable clinical course.


Subject(s)
Brain Neoplasms/pathology , Glioma/pathology , Adult , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/surgery , Diagnosis, Differential , Female , Ganglioglioma/pathology , Glioma/diagnostic imaging , Glioma/surgery , Humans , Magnetic Resonance Imaging , Male , Neurocytoma/pathology , Tomography, X-Ray Computed , Treatment Outcome
13.
Neurology ; 52(8): 1648-51, 1999 May 12.
Article in English | MEDLINE | ID: mdl-10331693

ABSTRACT

OBJECTIVE: To report a series of HIV-infected patients with intracranial tumors not known to be associated with immunodeficiency. BACKGROUND: The spectrum of HIV-associated diseases is changing with improved treatments and prolonged patient survival. Although primary central nervous system lymphoma (PCNSL) and toxoplasmosis continue to be the most common intracranial lesions in HIV-infected patients, the recognition of other pathologic entities is increasingly important. METHODS: The clinical characteristics and outcome of eight HIV-infected patients with nine intracranial neoplasms other than PCNSL are reported. In addition, all available pathologic specimens were tested for evidence of either HIV or Epstein-Barr virus (EBV) infection. An additional 28 patients reported in the literature are summarized. RESULTS: Five of eight patients had a glioblastoma multiforme; other tumors included an anaplastic ependymoma, a low-grade glioma, a subependymoma, and a leiomyosarcoma. More than half of the patients developed their tumor > or =6 years after the diagnosis of HIV infection. Patient prognosis and survival was best predicted by tumor histology. Treatment response and outcome did not appear to be influenced by HIV infection. Only the leiomyosarcoma demonstrated evidence of latent EBV infection. CONCLUSIONS: HIV-infected patients are at risk for intracranial neoplasms other than PCNSL, and benefit from aggressive tumor-specific therapy. It is possible that gliomas are occurring at a higher rate than in the general population. There was no evidence of HIV or EBV infection in any glial tumor.


Subject(s)
Brain Neoplasms/complications , HIV Infections/complications , Adult , Biopsy , Brain Neoplasms/pathology , Brain Neoplasms/physiopathology , Female , Humans , Male , Middle Aged , Prognosis
14.
Neurology ; 52(1): 193-5, 1999 Jan 01.
Article in English | MEDLINE | ID: mdl-9921876

ABSTRACT

The authors describe specific MRI features that suggest the diagnosis of varicella zoster encephalitis. MRI initially revealed discrete, subcortical, nonenhancing lesions that coalesced and developed enhancement. Gray matter involvement was seen later. Autopsy revealed spherical lesions of demyelination and hemorrhagic cavitation confirmed as varicella zoster encephalitis. Characteristic MR features may suggest the diagnosis of varicella zoster encephalitis, enabling definitive diagnostic testing and early institution of antiviral treatment.


Subject(s)
Encephalitis, Viral/immunology , Encephalitis, Viral/virology , Herpes Zoster/immunology , Immunocompromised Host , Adult , Brain/immunology , Brain/virology , Encephalitis, Viral/diagnosis , Female , Herpes Zoster/diagnosis , Humans , Magnetic Resonance Imaging , Male
15.
J Neurooncol ; 44(2): 147-53, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10619498

ABSTRACT

High dose chemotherapy (HDCT) with autologous (bone marrow or peripheral blood) stem cell rescue (ASCR) has had success in the treatment of some malignant pediatric brain tumors. We report a series of adults enrolled in one of three HDCT and ASCR protocols for malignant primary brain tumors. Overall toxic mortality was 18%; chemotherapy regimen, tumor type, and prior treatment did not predict transplant-related mortality. Patients over the age of 30 had a higher rate of toxic mortality. Patients with recurrent medulloblastoma had a significant improvement in long-term survival (median: 34 months) as compared with historical reports; two patients with glioblastoma survive beyond four years without progression, but overall, a significant improvement in long-term survival could not be demonstrated for malignant gliomas.


Subject(s)
Antineoplastic Agents/administration & dosage , Brain Neoplasms/therapy , Hematopoietic Stem Cell Transplantation , Salvage Therapy , Adolescent , Adult , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Brain Neoplasms/mortality , Combined Modality Therapy , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Survival Analysis , Transplantation, Autologous , Treatment Outcome
16.
J Neurooncol ; 39(3): 261-5, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9821112

ABSTRACT

Isolated neurosarcoidosis can present with a wide range of central nervous system manifestations. We present two cases of cauda equina sarcoidosis misdiagnosed initially as leptomeningeal malignancy, and review the literature. This unusual manifestation of neurosarcoidosis is typified by an indolent, chronic process with limited response to corticosteroid therapy.


Subject(s)
Cauda Equina/pathology , Meningeal Neoplasms/diagnosis , Peripheral Nervous System Diseases/diagnosis , Sarcoidosis/diagnosis , Diagnosis, Differential , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged
17.
Am J Surg Pathol ; 22(10): 1171-83, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9777979

ABSTRACT

We describe the clinicopathologic features of nine cases of a unique papillary glioneuronal tumor (PGNT) exhibiting astrocytic as well as extensive and varied neuronal differentiation. The four male and five female patients studied ranged in age from 11 to 52 years (mean 27.7 years). They either presented with mild neurologic symptoms or were asymptomatic. Magnetic resonance imaging showed demarcated cystic, 1.5-cm to 7-cm contrast-enhancing masses; five involved the temporal lobe, two the parietal, and two the frontal. All but one were totally resected. No recurrence was noted despite a follow-up period of 3 years. Two microscopic components were evident: 1) compact pseudopapillae composed of hyalinized vessels covered by a single layer of glial fibrillary acid protein (GFAP)-positive astrocytes and 2) synaptophysin-positive neuronal cells of varying size, including neurocytes, ganglioid cells, and ganglion cells within neuropil. Immunostains for chromogranin-A were negative, as was in situ hybridization for chromogranin-A mRNA. Ultrastructurally, neuronal cells featured microtubule-containing processes and aberrant synaptic terminals, but dense core granules were rare. Overall, cellularity was moderate and atypia was minimal. No mitotic activity or necrosis was noted. The proportions of the two components varied, but essential morphologic findings were identical in all cases. In that the clinical, radiographic, and morphologic characteristics of PGNT are distinctive, it appears to represent a previously undescribed form of mixed neuronal-glial tumor of the central nervous system.


Subject(s)
Brain Neoplasms/pathology , Brain/pathology , Ganglioglioma/pathology , Neurocytoma/pathology , Adolescent , Adult , Brain/diagnostic imaging , Brain/surgery , Brain Neoplasms/metabolism , Brain Neoplasms/surgery , Child , Female , Ganglioglioma/metabolism , Ganglioglioma/surgery , Glial Fibrillary Acidic Protein/metabolism , Humans , Immunoenzyme Techniques , Magnetic Resonance Imaging , Male , Middle Aged , Neurocytoma/metabolism , Neurocytoma/surgery , S100 Proteins/metabolism , Tomography, X-Ray Computed
19.
Pediatr Neurosurg ; 28(1): 27-30, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9693326

ABSTRACT

We report an unusual case of an intraparenchymal clear cell meningioma of the brainstem, occurring in a 22-month-old girl. She presented with bulbar dysfunction and a right hemiparesis due to an intrinsic tumor of the medulla, which was confirmed by radiologic imaging to be focal and with an exophytic component. At surgery, a partial resection was achieved and no dural attachment was found. Pathologic examination revealed a clear cell meningioma. In reviewing the literature, there have been fewer than 20 reported cases of clear cell meningioma, none of which were intraparenchymal, involved the brainstem or occurred in such a young patient. The pathologic findings, treatment options and present understanding of this tumor are discussed.


Subject(s)
Brain Neoplasms , Brain Stem , Meningeal Neoplasms , Meningioma , Adolescent , Adult , Age of Onset , Aged , Aged, 80 and over , Brain Neoplasms/classification , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Child , Child, Preschool , Female , Humans , Meningeal Neoplasms/classification , Meningeal Neoplasms/pathology , Meningeal Neoplasms/surgery , Meningioma/classification , Meningioma/pathology , Meningioma/surgery , Middle Aged , Radiosurgery
20.
Am J Surg Pathol ; 22(2): 195-200, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9500220

ABSTRACT

Anti-Hu is a polyclonal immunoglobulin G associated with a syndrome of paraneoplastic sensory neuropathy/encephalomyelitis that principally afflicts patients with small cell lung carcinoma. Anti-Hu antibodies, which identify a family of RNA-binding proteins that are normally neuron restricted and that appear to be integral to neuronal differentiation and maintenance, selectively label the nuclei (and, less strongly, the cytoplasm) of neurons throughout the human neuraxis. Small cell carcinomas of the lung and many neuroblastomas are also labeled. We screened 112 tumors of central neuroepithelial lineage for immunohistochemical evidence of Hu expression with anti-Hu immunoglobulin G that was purified from patient sera and with a recombinant Fab fragment (Fab GLN 495) selected from a patient-derived combinatorial antibody phage display library using a recombinant Hu protein (HuD). Both antibodies uniformly labeled, in addition to native neurons, the nuclei of central neurocytomas (6 of 6) and the neuronal components of "classic" (12 of 12) and desmoplastic infantile (2 of 2) gangliogliomas. Of 33 embryonal tumors, 29 were anti-Hu reactive, including 87% of medulloblastomas (26 of 30). Glial neoplasms (n = 59) were anti-Hu negative save for one "oligodendroglioma" (of 17 oligodendroglial/oligoastrocytic tumors) that may have been an extraventricular neurocytoma. Anti-Hu immunoglobulin G/Fab GLN 495 identifies neoplasms of differentiated neuronal type and embryonal tumors with neuronogenic potential.


Subject(s)
Biomarkers, Tumor , Brain Neoplasms/pathology , Neoplasms, Neuroepithelial/pathology , Nerve Tissue Proteins , Neurons/pathology , RNA-Binding Proteins/immunology , Antibodies, Neoplasm/immunology , Brain Neoplasms/immunology , Cell Differentiation/immunology , ELAV Proteins , ELAV-Like Protein 4 , Humans , Neoplasms, Neuroepithelial/immunology , Neurons/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...